MedMen Enterprises Inc. MMNFF's fiscal third-quarter results saw increased revenue by 22 percent to $36.6 million across operations in California, Nevada, New York, Arizona and Illinois.
MedMen continued to perform favorably in California with $24.9 million in retail revenue and retail gross margins increasing to 57 percent.
MedMen reported its revenue from pending acquisitions and pre-closing revenue from recently closed acquisitions, pro forma quarterly revenue was approximately $57 million.
MedMen decreased corporate selling, general and administrative expense by 9 percent quarter over quarter with a plan to achieve an overall 20 percent reduction from the previous quarter. The company also announced a $250 million financing commitment from Gotham Green Partners.
MedMen's stock traded around $2.37 per share at time of publication.
Related Links:
Cresco Labs Reports Q1 Sales Of $21.1M, Up 313% Year Over Year
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.